Skip Navigation LinksHome > Current Issue > Contributor Index

August 2014 - Volume 24 - Issue 8 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 2 Next
Author Name Article
Abboud, Miguel R.

Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Aklillu, Eleni

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Purchase Access
PDF
+ Favorites
Request Permissions
Akra-Ismail, Maya

Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Altman, Russ B.

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Purchase Access
PDF
+ Favorites
Request Permissions
Aridi, Carol

Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bae, Jung-Woo

Response to Suarez-Kurtz’s comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals

Purchase Access
PDF
+ Favorites
Request Permissions
Baslund, Bo

Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boukouvala, Sotiria

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Purchase Access
PDF
+ Favorites
Request Permissions
Byeon, Ji-Yeong

Response to Suarez-Kurtz’s comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals

Purchase Access
PDF
+ Favorites
Request Permissions
Choi, Chang-Ik

Response to Suarez-Kurtz’s comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals

Purchase Access
PDF
+ Favorites
Request Permissions
Drozdzik, Marek

Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dziewanowski, Krzysztof

Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
El Rouby, Nihal

The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Enevold, Christian

Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Goldstein, Joyce A.

The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hein, David W.

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Purchase Access
PDF
+ Favorites
Request Permissions
Jacobsen, Søren

Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Jang, Choon-Gon

Response to Suarez-Kurtz’s comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals

Purchase Access
PDF
+ Favorites
Request Permissions
Johnson, Julie A.

The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Josephsen, Norah L.

Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 2 Next